Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. [electronic resource]
Producer: 20191112Description: 919-926 p. digitalISSN:- 1528-0020
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- genetics
- Central Nervous System Neoplasms -- drug therapy
- Female
- Follow-Up Studies
- Humans
- Incidence
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Middle Aged
- Mutation
- Neoplasm Recurrence, Local -- diagnosis
- Predictive Value of Tests
- Proto-Oncogene Proteins c-bcl-2 -- genetics
- Proto-Oncogene Proteins c-myc -- genetics
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.